TOSS, ANGELA
Dettaglio
TOSS, ANGELA
Dipartimento Chirurgico,Medico,Odontoiatrico e di Scienze Morfologiche con interesse Trapiantologico, Oncologico e di Medicina Rigenerativa
Pubblicazioni
Risultati 1 - 20 di 59 (tempo di esecuzione: 0.002 secondi).
Titolo | Data di pubblicazione | Autore(i) | |
---|---|---|---|
1 | Acceptability and adherence in a chemoprevention trial among women at increased risk for breast cancer attending the Modena Familial Breast and Ovarian Cancer Center | 2013 | Razzaboni, Elisabetta; Toss, Angela; Cortesi, Laura; Marchi, I.; Sebastiani, Federica; DE MATTEIS, Elisabetta; Federico, Massimo |
2 | The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life | 2015 | Grandi, Giovanni; Toss, Angela; Cortesi, Laura; Botticelli, Laura; Volpe, Annibale; Cagnacci, Angelo |
3 | Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness | 2020 | Patel, V. L.; Busch, E. L.; Friebel, T. M.; Cronin, A.; Leslie, G.; McGuffog, L.; Adlard, J.; Agata, S.; Agnarsson, B. A.; Ahmed, M.; Aittom, K.; Alducci, E.; Andrulis, I. L.; Arason, A.; Arnold, N.; Artioli, G.; Arver, B.; Auber, B.; Azzollini, J.; Balmana, J.; Barkardottir, R. B.; Barnes, D. R.; Barroso, A.; Barrowdale, D.; Belotti, M.; Benitez, J.; Bertelsen, B.; Blok, M. J.; Bodrogi, I.; Bonadona, V.; Bonanni, B.; Bondavalli, D.; Boonen, S. E.; Borde, J.; Borg, A.; Bradbury, A. R.; Brady, A.; Brewer, C.; Brunet, J.; Buecher, B.; Buys, S. S.; Cabezas-Camarero, S.; Caldes, T.; Caliebe, A.; Caligo, M. A.; Calvello, M.; Campbell, I. G.; Carnevali, I.; Carrasco, E.; Chan, T. L.; Chu, A. T. W.; Chung, W. K.; Claes, K. B. M.; Cook, J.; Cortesi, L.; Couch, F. J.; Daly, M. B.; Damante, G.; Darder, E.; Davidson, R.; De La Hoya, M.; Della Puppa, L.; Dennis, J.; Diez, O.; Ding, Y. C.; Ditsch, N.; Domchek, S. M.; Donaldson, A.; Dworniczak, B.; Easton, D. F.; Eccles, D. M.; Eeles, R. A.; Ehrencrona, H.; Ejlertsen, B.; Engel, C.; Evans, D. G.; Faivre, L.; Faust, U.; Feliubadalo, L.; Foretova, L.; Fostira, F.; Fountzilas, G.; Frost, D.; Garcia-Barberan, V.; Garre, P.; Gauthier-Villars, M.; Geczi, L.; Gehrig, A.; Gerdes, A. -M.; Gesta, P.; Giannini, G.; Glendon, G.; Godwin, A. K.; Goldgar, D. E.; Greene, M. H.; Gutierrez-Barrera, A. M.; Hahnen, E.; Hamann, U.; Hauke, J.; Herold, N.; Hogervorst, F. B. L.; Honisch, E.; Hopper, J. L.; Hulick, P. J.; Izatt, L.; Jager, A.; James, P.; Janavicius, R.; Jensen, U. B.; Jensen, T. D.; Johannsson, O. Th.; John, E. M.; Joseph, V.; Kang, E.; Kast, K.; Kiiski, J. I.; Kim, S. -W.; Kim, Z.; Ko, K. -P.; Konstantopoulou, I.; Kramer, G.; Krogh, L.; Kruse, T. A.; Kwong, A.; Larsen, M.; Lasset, C.; Lautrup, C.; Lazaro, C.; Lee, J.; Lee, J. W.; Lee, M. H.; Lemke, J.; Lesueur, F.; Liljegren, A.; Lindblom, A.; Llovet, P.; Lopez-Fernandez, A.; Lopez-Perolio, I.; Lorca, V.; Loud, J. T.; Ma, E. S. K.; Mai, P. L.; Manoukian, S.; Mari, V.; Martin, L.; Matricardi, L.; Mebirouk, N.; Medici, V.; Meijers-Heijboer, H. E. J.; Meindl, A.; Mensenkamp, A. R.; Miller, C.; Gomes, D. M.; Montagna, M.; Mooij, T. M.; Moserle, L.; Mouret-Fourme, E.; Mulligan, A. M.; Nathanson, K. L.; Navratilova, M.; Nevanlinna, H.; Niederacher, D.; Cilius Nielsen, F. C.; Nikitina-Zake, L.; Offit, K.; Olah, E.; Olopade, O. I.; Ong, K. -R.; Osorio, A.; Ott, C. -E.; Palli, D.; Park, S. K.; Parsons, M. T.; Pedersen, I. S.; Peissel, B.; Peixoto, A.; Perez-Segura, P.; Peterlongo, P.; Petersen, A. H.; Porteous, M. E.; Pujana, M. A.; Radice, P.; Ramser, J.; Rantala, J.; Rashid, M. U.; Rhiem, K.; Rizzolo, P.; Robson, M. E.; Rookus, M. A.; Rossing, C. M.; Ruddy, K. J.; Santos, C.; Saule, C.; Scarpitta, R.; Schmutzler, R. K.; Schuster, H.; Senter, L.; Seynaeve, C. M.; Shah, P. D.; Sharma, P.; Shin, V. Y.; Silvestri, V.; Simard, J.; Singer, C. F.; Skytte, A. -B.; Snape, K.; Solano, A. R.; Soucy, P.; Southey, M. C.; Spurdle, A. B.; Steele, L.; Steinemann, D.; Stoppa-Lyonnet, D.; Stradella, A.; Sunde, L.; Sutter, C.; Tan, Y. Y.; Teixeira, M. R.; Teo, S. H.; Thomassen, M.; Tibiletti, M. G.; Tischkowitz, M.; Tognazzo, S.; Toland, A. E.; Tommasi, S.; Torres, D.; Toss, A.; Trainer, A. H.; Tung, N.; Van Asperen, C. J.; Van Der Baan, F. H.; Van Der Kolk, L. E.; Van Der Luijt, R. B.; Van Hest, L. P.; Varesco, L.; Varon-Mateeva, R.; Viel, A.; Vierstrate, J.; Villa, R.; Von Wachenfeldt, A.; Wagner, P.; Wang-Gohrke, S.; Wappenschmidt, B.; Weitzel, J. N.; Wieme, G.; Yadav, S.; Yannoukakos, D.; Yoon, S. -Y.; Zanzottera, C.; Zorn, K. K.; D'Amico, A. V.; Freedman, M. L.; Pomerantz, M. M.; Chenevix-Trench, G.; Antoniou, A. C.; Neuhausen, S. L.; Ottini, L.; Nielsen, H. R.; Rebbeck, T. R. |
4 | Brca detection rate in an italian cohort of luminal early-onset and triple-negative breast cancer patients without family history: When biology overcomes genealogy | 2020 | Toss, A.; Molinaro, E.; Venturelli, M.; Domati, F.; Marcheselli, L.; Piana, S.; Barbieri, E.; Grandi, G.; Piombino, C.; Marchi, I.; Tenedini, E.; Tagliafico, E.; Tazzioli, G.; Cortesi, L. |
5 | BRCA mutations among triple negative breast cancer without family history of breast and ovarian cancer: The Modena family cancer clinic experience | 2019 | Molinaro, E.; Venturelli, M.; Toss, A.; Piombino, C.; Barbieri, E.; Marcheselli, L.; Marchi, I.; Tagliafico, E.; Cascinu, S.; Cortesi, L. |
6 | Breast ultrasonography (BU) in the screening protocol for women at hereditary-familial risk of breast cancer: has the time come to rethink the role of BU according to different risk categories? | 2019 | Cortesi, Laura; Canossi, Barbara; Battista, Rachele; Pecchi, Annarita; Drago, Antonella; Dal Molin, Chiara; Toss, Angela; De Matteis, Elisabetta; Marchi, Isabella; Torricelli, Pietro; Cascinu, Stefano |
7 | Breast ultrasound in high-risk women | 2019 | Cortesi, Laura; Barbieri, Elena; Toss, Angela |
8 | Cancer Treatment Induced Bone Loss (CTIBL) in breast cancer women: a multidisciplinary approach at the Modena Cancer Center screening over 600 patients. | 2018 | Pozzi, S.; Belletti, L.; Cortesi, L.; Moscetti, L.; Omarini, C.; Piacentini, F.; Toss, A.; Caputo, Francesco; Greco, S.; Isca, C.; Napolitano, M.; Tarantino, V.; Malinverni, C.; Checchi, Eleonora; Mascia, Maria Teresa; Cascinu, S |
9 | Chemoprevention strategies for high risk women | 2012 | Toss, A.; Sebastiani, F.; Razzaboni, E.; de Matteis, E.; Marchi, I.; Proietto, M.; Cortesi, L. |
10 | Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients. | 2018 | Omarini, C; Bettelli, S; Caprera, C; Manfredini, S; Caggia, F; Guaitoli, G; Moscetti, L; Toss, A; Cortesi, L; Kaleci, S; Maiorana, A; Cascinu, S; Conte, Pf; Piacentini, F |
11 | Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. | 2019 | Barbolini, M; Omarini, C; Viola, L; Isca, C; Marchi, I; Caggia, F; Barbieri, E; Toss, A; Cortesi, L; Dominici, M; Piacentini, F. |
12 | Clinical-pathological features and treatment modalities associated with recurrence in DCIS and micro-invasive carcinoma: Who to treat more and who to treat less | 2016 | Toss, A.; Palazzo, J.; Berger, A.; Guiles, F.; Sendecki, J. A.; Simone, N.; Anne, R.; Avery, T.; Jaslow, R.; Lazar, M.; Tsangaris, T.; Cristofanilli, M. |
13 | Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: To prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials | 2020 | Omarini, C.; Piacentini, F.; Sperduti, I.; Barbolini, M.; Isca, C.; Toss, A.; Cortesi, L.; Barbieri, E.; Dominici, M.; Moscetti, L. |
14 | Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History | 2018 | Grandi, Giovanni; Toss, Angela; Cagnacci, Angelo; Marcheselli, Luigi; Pavesi, Silvia; Facchinetti, Fabio; Cascinu, Stefano; Cortesi, Laura |
15 | Combined hormonal contraceptives in BRCA gene mutation carriers: why not? | 2019 | Grandi, Giovanni; Sammarini, Margaret; Del Savio, Maria Chiara; Toss, Angela; Facchinetti, Fabio |
16 | CTC enumeration and characterization: Moving toward personalized medicine | 2014 | Toss, A.; Mu, Z.; Fernandez, S.; Cristofanilli, M. |
17 | Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. | 2019 | Omarini, C; Bettelli, S; Caprera, C; Manfredini, S; Barbolini, M; Moscetti, L; Isca, C; Toss, A; Barbieri, E; Cortesi, L; Kaleci, S; Maiorana, A; Tazzioli, G; Cascinu, S; Piacentini, F |
18 | Endocrine sensitive metastatic breast cancer and bone only disease: are the new treatments always better? | 2018 | Toss, A.; Venturelli, M.; Sperduti, I.; Isca, C.; Barbieri, E.; Piacentini, F.; Omarini, C.; Cortesi, L; Cascinu, Stefano; Moscetti, L. |
19 | Endocrine therapy alone versus targeted combination strategy as first line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trial | 2019 | Omarini, C; Sperduti, I; Barbolini, M; Isca, C; Bocconi, Alessandro; Toss, A; Cortesi, L; Barbieri, E; Piacentini, F; Cascinu, S; Moscetti, L |
20 | ERBB2 mutations in hormone receptor positive primary breast cancers samples and in their matched endocrine-resistant recurrences. | 2018 | Venturelli, M.; Toss, A.; Piacentini, F.; Artuso, L.; Bernardis, I.; Parenti, S.; Tenedini, E.; Omarini, C.; Moscetti., 1; Cascinu, S.; Tagliafico, E.; Cortesi, L. |